Living with or without cyclins and cyclin-dependent kinases
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Entry into, progression through, and exit from the G1 phase of the mammalian cell cycle in response to extracellular mitogenic cues are presumed to be governed by cyclin-dependent kinases (Cdks) regulated by the D-type and E-type cyclins. Studies performed over more than a decade have supported the view that these holoenzymes are important, if not required, for these processes. However, recent experiments in which the genes encoding all three D-type cyclins, the two E-type cyclins, cyclin D-dependent Cdk4 and Cdk6, or cyclin E-dependent Cdk2 have been disrupted in the mouse germ line have revealed that much of fetal development occurs normally in their absence. Thus, none of these genes is strictly essential for cell cycle progression. To what extent is the prevailing dogma incorrect, and how can the recent findings be reconciled with past work?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the high frequency of mutations epistatically targeting the RB signaling pathway in cancer cells, inactivation of the individual cyclin D, Cdk4/6, and Ink4a genes in mice, while leading to specific developmental defects when disrupted alone or in combination, established that their functions were nonessential for the cell cycle per se (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it may well prove that mutations affecting other cell cycle regulators, such as amplification of cyclin E, loss of p27Kip1 or p21Cip1 and activation of CDK2 would bypass the requirement of tumor cells for CDK4/6 activity, thereby also conferring de novo resistance (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“…the idea that mutant " cancer stem cells, " rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance and, in turn, for resistance to therapy (Reya et al. 2001; Taipale and Beachy 2001; Al-Hajj et al. 2003).”
BackgroundStem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738 · cited 2×
“The cells that give rise to many cancers have both the self-renewal and differentiating capacities of tissue stem cells, raising the idea that mutant “cancer stem cells,” rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance…”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · cited 1×
“The AKT kinase controls the subcellular localization of Cip/Kip proteins as well (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002), providing yet another avenue for cyclin E–Cdk2 regulation in response to extracellular cues.”
BackgroundSelf-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 2×
“1994); conversely, attenuation of Cdk4 activity by polypeptide inhibitors of the INK4 gene family (Serrano et al. 1993) or by Cdk4-selective drugs (Tetsu and McCormick 2003) results in G1-phase arrest and cell cycle exit.”
BackgroundInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243 · cited 6×
“1993), and by induction of polypeptide inhibitors of the Cip/Kip family in many physiologic settings (Sherr and Roberts 1995) result in G1-phase arrest.”
BackgroundInfluentialSelf-citationG1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674 · cited 1×
“If this occurs before the G1/S boundary, cells exit the cycle without replicating their DNA, but if it occurs afterward, cells complete mitosis and exit from the cycle in the next G1 interval (Matsushime et al. 1994; Sherr 1994).”
BackgroundSelf-citationCYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259 · cited 3×
“The relevant proteins include three D-type cyclins (D1, D2, and D3) that, in different combinations, bind to, and allosterically regulate, one of two Cdk subunits, Cdk4 and Cdk6, as well as the E-type cyclins (E1 and E2), which, in analogous fashion, govern the activity of a single catalytic subunit, Cdk2 (Morgan 1997…”
BackgroundInfluentialGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 2×
“…GSK-3, an enzyme that is inhibited by the phosphatidylinositol 3-kinase/AKT signaling pathway , in determining the stability of cyclin E implies that its life history, like that of cyclin D1 (Diehl et al. 1998), can be directly influenced by at least one mitogen-dependent kinase signaling cascade.”
BackgroundSelf-citationPolyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954 · cited 1×
“, two potent inhibitors of Cdk2 (Polyak et al. 1994; Reynisdottir et al. 1995; Sherr and Roberts 1995).”
Self-citationCyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614 · cited 2×
“In continuously dividing cells, cyclin D1 exits the cell nucleus during S phase, and its turnover is accelerated throughout this interval (Baldin et al. 1993; Diehl et al. 1998), but Rasdependent cyclin D1 synthesis and its stabilization in G2 phase allow it to reaccumulate before cells divide (Guo…”
Background
Research works printed but not linked: 1
- Resnitzky, D., Gossen, M., Bujard, H., and Reed, S.I. 1994. Ac- celeration of the G1/S phase transition by expression of cy- clins D1 and E with an inducible system. Mol. Cell. Biol. 14: 1669-1679.
Cited by
Items 701–800 of 1,000
Quan, X., Liang, C., Sun, M., Zhang, L., & Li, X. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0109-4 · Cited by 15
Gold, M., Köhler, L. H. F., Lanzloth, C., Andronache, I., Anant, S., Dandawate, P. R., Biersack, B., & Schobert, R. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112060 · Cited by 14
Jin, X., Wang, J., Hu, J., Liu, X., Li, S., Lu, Y., Zhen, H., Li, M., Zhao, Z., & Luo, Y. (2021) · Animals · doi:10.3390/ani11082417 · Cited by 14
“CDK2, CDK4, CCNB1 and CCND1 can accelerate the cell cycle moving from G1 to S phase and then promote the proliferation of various cell types including mouse embryonic fibroblasts [29], mouse neural progenitor cells [30] and human hepatocellular carcinoma [31].”
BackgroundSP1 enhances Zbtb7A gene expression via direct binding to GC box in HePG2 cells
Zu, X., Yu, L., Sun, Q., Liu, F., Wang, J., Xie, Z., Wang, Y., Xu, W., & Jiang, Y. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-175 · Cited by 14
“Many Sp1 targeting genes, such as CyclinE, Cdk2, E2F1 and c-Myc, are key regulator of cell proliferation and carcinogenesis [27,28].”
BackgroundZhao, Y., Lou, I. C., & Conolly, R. B. (2011) · Dose-Response · doi:10.2203/dose-response.11-021.zhao · Cited by 14
Hu, X., Moon, J. W., Li, S., Xu, W., Wang, X., Liu, Y., & Lee, J.-Y. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.16845 · Cited by 14
“[13] Previous studies have especially proposed the important role of CCND1 and CTTN in ESCC.”
BackgroundInfluentialPatel, R. S., Islam, S. A., Bommareddy, R. R., Smalley, T. B., & Acevedo-Duncan, M. E. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5021 · Cited by 14
Xiang, Q., Xu, F., Li, Y., Liu, X., Chen, Q., Huang, J., Yu, N., Zeng, Z., Yuan, M., Zhang, Q., et al. (2020) · Gland Surgery · doi:10.21037/gs.2020.02.09 · Cited by 14
“CDK1 has always been regarded as the master regulator of cell cycle; and other CDKs without exception cannot replace its function (44-46).”
BackgroundSmall-Molecule Degraders of Cyclin-Dependent Kinase Protein: A Review
Yu, B., Du, Z., Zhang, Y., Li, Z., & Bian, J. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0154 · Cited by 15
Role of Cell Division Autoantigen 1 (CDA1) in Cell Proliferation and Fibrosis
Toh, B., Tu, Y., Cao, Z., Cooper, M. E., & Chai, Z. (2010) · Genes · doi:10.3390/genes1030335 · Cited by 15
“These activities cannot be attributed solely to induction of p21 expression as p21 plays a positive role in regulating activities of the D type cyclins-Cdk 4/6 [55–58], by promoting formation of active cyclin/Cdk complexes.”
BackgroundFang, S., Zhang, K., Wang, T., Wang, X., Lü, X., Peng, B., Wu, W., Zhang, R., Chen, S., Zhang, R., et al. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5852-y · Cited by 14
“IL6, IFNG, and CDKN1A appearing as hub proteins may play prominent roles in regulating the severity of 2009A-associated disease relative to seasonal influenza virus, since these proteins are known as inhibitor of cell cycle (Sherr and Roberts 2004).”
InfluentialTomoda, C., Moatamed, F., Naeim, F., Hershman, J. M., & Sugawara, M. (2008) · Experimental Biology and Medicine · doi:10.3181/0804-rm-127 · Cited by 14
Golen, K. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1111-7 · Cited by 17
Mitochondria and the cell cycle in budding yeast
Leite, A. C., Costa, V., & Pereira, C. (2023) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2023.106444 · Cited by 16
Cyclin D1—Cdk4 regulates neuronal activity through phosphorylation of GABAA receptors
Pedraza, N., Monserrat, M. V., Ferrezuelo, F., Torres‐Rosell, J., Colomina, N., Míguez‐Cabello, F., Picañol, J., Soto, D., López-Merino, E., Vilela, C. G., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04920-7 · Cited by 13
“Cyclin D1 (Ccnd1) and its catalytic counterparts, cyclindependent kinase 4 (Cdk4) and Cdk6, are main regulators of cell proliferation by promoting the G1–S phase transition of the cell cycle (reviewed in [1]).”
BackgroundClinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer
Zhu, J., Zhang, Y., Yang, X., & Jin, L. (2017) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2016.2163 · Cited by 13
“CDK2 has been reported to regulate the G1 to S phase transition during the late G1 phase.(20) Bax is a representative member of the Bcl-2 family that promotes apoptosis.”
Screening for Potential Biomarkers in Peripheral Blood From Miners Exposed to Radon Radiation
Sun, L., Pan, Y., Wang, X., Gao, G., Wu, L., Piao, C., Ruan, J., & Liu, J. (2020) · Dose-Response · doi:10.1177/1559325820904600 · Cited by 13
“CyclinD activates CDK4/CDK6 to initiate the cell cycle in the early G1 phase; CyclinE activates CDK2 in the late G1 phase; Cyclin A/CDK2 and Cyclin B/CDK1 participate in mitosis.(8,9) Further research on the changes in lymphocytes induced by radon in the blood is crucial.”
BackgroundCytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm
Sakamoto, K., & Takeuchi, K. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2020.01.003 · Cited by 15
Zhao, L., Pan, Y., Wang, M., Wang, J., Wang, Y., Han, X., Wang, J., Zhang, T., Zhao, T., He, H., et al. (2022) · BMC Genomics · doi:10.1186/s12864-022-08848-3 · Cited by 14
“Cyclin D1 is encoded by the CCND1 gene located on chromosome band 11q13 and promotes cell cycle progression during the G1-S phase [57].”
BackgroundLing, H., Samarasinghe, S., & Kulasiri, D. (2012) · Biosystems · doi:10.1016/j.biosystems.2012.12.001 · Cited by 14
Al‐Assar, O., Rees‐Unwin, K. S., Menasce, L. P., Hough, R. E., Goepel, J. R., Hammond, D. W., & Hancock, B. W. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06093.x · Cited by 16
“Essential for oncogenic transformation could be the interplay among CDK2, CDK4 and Cip/Kip proteins (Zou et al, 2002; Sherr & Roberts, 2004).”
BackgroundA trip through the signaling pathways of melanoma
Fensterle, J. (2006) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2006.05925.x · Cited by 17
DeMicco, A., Reich, T. J., Arya, R. S., Rivera-Reyes, A., Fisher, M. R., & Bassing, C. H. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1198861 · Cited by 13
Signal Transduction Involving the Dmp1 Transcription Factor and its Alteration in Human Cancer
Sugiyama, T., Frazier, D. P., Taneja, P., Kendig, R. D., Morgan, R. L., Matise, L. A., Lagedrost, S. J., & Inoue, K. (2008) · Clinical medicine Oncology · doi:10.4137/cmo.s548 · Cited by 15
Li, L., Li, J., Li, X., & Fa-huan, Y. (2017) · PubMed · Cited by 13
CASIN and AMD3100 enhance endothelial cell proliferation, tube formation and sprouting
Kalkan, B. M., Akgöl, S., Ak, D., Yücel, D., Güney-Esken, G., & Kocabaş, F. (2020) · Microvascular Research · doi:10.1016/j.mvr.2020.104001 · Cited by 13
Cyclin E2 is required for embryogenesis in Xenopus laevis
Gotoh, T., Shigemoto, N., & Kishimoto, T. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.08.005 · Cited by 13
“…cyclin D-dependent Cdk4 and Cdk6, or cyclin E-dependent Cdk2] have revealed that much of fetal development occurs normally in their absence (Berthet et al., 2003, 2006; Geng et al., 2003; Kozar et al., 2004; Malumbres et al., 2004; Ortega et al., 2003; Parisi et al., 2003; Sherr and Roberts, 2004).”
BackgroundCyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA‐binding capacity
Scimè, A., Li, L., Ciavarra, G., & Whyte, P. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21243 · Cited by 14
“Supernatants were assayed for CAT and luciferase activities as previously described (Sleigh, 1986; De Wet et al., 1987).”
MethodSandoval, R., Xue, J., Tian, X., Barrett, K., Pilkinton, M. A., Ucker, D. S., Raychaudhuri, P., Kineman, R. D., Luque, R. M., Baida, G. E., et al. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.04.002 · Cited by 15
“[1] C.”
BackgroundDynamic Green Fluorescent Protein Sensors for High‐Content Analysis of the Cell Cycle
Stubbs, S. L. J., & Thomas, N. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)14001-x · Cited by 13
Sulaksono, H. L. S., Annisa, A., Ruslami, R., Mufeeduzzaman, M., Panatarani, C., Hermawan, W., Ekawardhani, S., & Joni, I. M. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s455940 · Cited by 14
Zou, Y., Li, Z., Lin, Y., Zheng, Y., Liu, Z., Li, Y., Huang, L., Chen, Z., & Zhu, L. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119168 · Cited by 12
O'Sullivan, C. C. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1201072 · Cited by 13
“phosphorylated, bind to partner cyclins and regulate G1-S phase transition (13, 14).”
Insights into the aberrant CDK4/6 signaling pathway as a therapeutic target in tumorigenesis
Rezaeian, A.-H., Inuzuka, H., & Wei, W. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.11.009 · Cited by 13
Coupling of the Cell Cycle and Apoptotic Machineries in Developing T Cells
Xue, L., Sun, Y., Chiang, L., He, B., Kang, C., Nolla, H. A., & Winoto, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035535 · Cited by 14
Hemangiopoietin Promotes Endothelial Cell Proliferation Through PI-3K/Akt Pathway
Chen, Z., Liu, F., Ren, Q., Zhao, Q., Ren, H., Lu, S., Zhang, L., & Han, Z. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000149809 · Cited by 12
Leptin-dependent neurotoxicity via induction of apoptosis in adult rat neurogenic cells
Segura, S., Efthimiadi, L., Porcher, C., Courtes, S., Coronas, V., Krantic, S. M., & Moyse, E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00350 · Cited by 13
“Given that cyclin D1 is one of the major regulators of cell division and growth (Sherr and Roberts, 2004) and the reported involvement of ERK pathway in the control of cyclin D1 expression (Lefloch et al., 2009), we sought to determine whether leptin might alter cyclin D1 expression in SVZ…”
BackgroundBoratyn, E., Nowak, I., Karnas, E., Ryszawy, D., Wnuk, D., Polus, A., Durbas, M., Horwacik, I., & Rokita, H. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29614 · Cited by 12
Potential use of kiwifruit extract for treatment of melanoma
Kou, L., Zhu, Z., Redington, C. G., Bai, Q., Wakefield, M. R., Lequio, M., & Fang, Y. (2021) · Medical Oncology · doi:10.1007/s12032-021-01465-2 · Cited by 12
Analyzing RB and E2F During the G1–S Transition
Thwaites, M. J., Cecchini, M. J., & Dick, F. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_24 · Cited by 12
Cigarette tar phenols impede T cell cycle progression by inhibiting cyclin-dependent kinases
Frazer‐Abel, A. A., McCue, J. M., Lazis, S., Portas, M. A., Lambert, C. L., & Freed, B. M. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.02.013 · Cited by 12
Cell Cycle: How Cyclin E Got Its Groove Back
Welcker, M., & Clurman, B. E. (2005) · Current Biology · doi:10.1016/j.cub.2005.09.018 · Cited by 12
Significance of Cyclin D1 Polymorphisms in Patients with Head and Neck Cancer
Sabir, M., Baig, R. M., Mahjabeen, I., & Kayani, M. A. (2012) · The International Journal of Biological Markers · doi:10.5301/jbm.2012.9768 · Cited by 12
“The CCND1 gene is located on chromosome 11q13, encodes the cyclin D1 protein and is expressed in response to mitogenic signals promoting transition through the restriction point in the G1 phase of the cell cycle (1).”
BackgroundSlotta‐Huspenina, J., Koch, I., Richter, M., Bink, K., Kremer, M., Specht, K., Krugmann, J., Quintanilla‐Martínez, L., & Fend, F. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.05.021 · Cited by 14
Liu, Q., Jiang, Z., Qiu, M., Andersen, M. E., Crabbe, M. J. C., Wang, X., Zheng, Y., & Qu, W. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c08150 · Cited by 11
Mansour, A. M., Arafa, M. M., Hegazy, Y. S., Sadek, M. S., Ibrahim, H. H., Abdullah, Y. S., & Shehab, O. R. (2025) · Dalton Transactions · doi:10.1039/d4dt03219e · Cited by 11
Yang, V. W. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00015-4 · Cited by 12
Divya, V., Pushpa, V. L., & Manoj, K. B. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.01.089 · Cited by 11
Zhang, Y., Wu, T., Li, F., Cheng, Y., Han, Q., Lu, X. B., Lü, S., & Xia, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.846744 · Cited by 12
“Under the stimulationof extracellular signals like mitogens, cytokines, cell–cell contacts and differentiation inducers, cyclin D promotes cell division by activating CDK4/6, which in turn phosphorylates the retinoblastoma (RB) tumor suppressor leading to unrestrained E2F transcription factors, E2F-dependent transcrip…”
BackgroundEfthimiadi, L., Farso, M. C., Quirion, R., & Krantic, S. M. (2012) · Neurodegenerative Diseases · doi:10.1159/000335911 · Cited by 11
CDK2 knockdown enhances head and neck cancer cell radiosensitivity
Soffar, A. A., Storch, K., Aleem, E. A., & Cordes, N. (2013) · International Journal of Radiation Biology · doi:10.3109/09553002.2013.782108 · Cited by 11
“In the late G1 phase, Cyclin E activates CDK2 thus completing Rb phosphorylation for G1/S phase transition through the Rb restriction point (Sherr and Roberts 1999, 2004).”
BackgroundLien, H.-W., Yuan, R.-Y., Chou, C., Chen, Y., Hung, C., Hu, C., Hwang, S. L., Hwang, P., Shen, C., Chen, C.-L., et al. (2016) · Scientific Reports · doi:10.1038/srep28297 · Cited by 11
Viloria, M. E., Bravo, J., Carrero, Y. N., & Mosquera, J. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.07.023 · Cited by 11
Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment
Kaur, S., Najm, M. Z., Khan, M. A., Akhter, N., Shingatgeri, V., Sikenis, M., Sadaf, S., & Aloliqi, A. A. (2021) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s343329 · Cited by 13
Tao, J., Yan, C., Tian, X., Liu, S., Li, Y., Zhang, J., Sun, M., Ma, X., & Han, Y. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918437 · Cited by 11
“CDK2 activity is commonly induced by E-type cyclins [26], but in the present study, induction of cyclin E by CREG did not result in a significant overexpression of CDK2.”
BackgroundRuiz-Miró, M., Colomina, N., Fernández-Hernández, R., Garí, E., Gallego, C., & Aldea, M. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01176.x · Cited by 11
“Thus, complex formation between Cdk4/6 and D-type cyclins is highly dependent on KIP proteins (6,18) and, as the three members of this family (p21Cip1, p27Kip1 and p57Kip2) contain nuclear localization signal (NLS) sequences, they have been proposed to direct nuclear import of the complex during G1 phase (19,20).”
BackgroundPharmacophore identification, docking and “in silico” screening for novel CDK1 inhibitors
Dong, X., Yan, J., Du, L., Wu, P., Huang, S., Liu, T., & Hu, Y. (2012) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2012.04.003 · Cited by 11
Guntaka, R. V., & Padala, M. K. (2014) · ISRN Virology · doi:10.1155/2014/351407 · Cited by 13
Han, S., No, J. H., Jeon, Y. T., Kim, J., Park, N. H., Song, Y. S., Kang, S., & Lee, H. P. (2008) · Human Reproduction · doi:10.1093/humrep/dem407 · Cited by 11
“The ability of CCND1 to activate cyclin-dependent kinase (CDK) 4 or 6 mediates phosphorylation of the retinoblastoma tumor suppressor gene protein, resulting in the release of E2F transcription factors to allow cells to enter into S phase (Sherr and Roberts, 2004).”
BackgroundCritical roles of Cyclin D1 in mouse embryonic fibroblast cell reprogramming
Oh, H., Kim, J., & Kim, J. (2016) · FEBS Journal · doi:10.1111/febs.13941 · Cited by 11
Carbone, C. J., Graña, X., Reddy, E. P., & Haines, D. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0499 · Cited by 12
“It was initially thought that Cdk4/Cdk6 and Cdk2 work sequentially on pRb and play essential and nonredundant roles in promoting cell cycle progression (3).”
BackgroundPromiscuous and lineage-specific roles of cell cycle regulators in haematopoiesis.
Myatt, S. S., & Lam, E. W. ‐. (2007) · Cell Division · doi:10.1186/1747-1028-2-6 · Cited by 19
“CDK4 and CDK6, bind to and are activated by the D-type cyclins, while CDK2 activity is induced by the E-type cyclins [9].”
BackgroundPastor-Alonso, O., Zahra, A. S., Kaske, B., García‐Moreno, F., Tetzlaff, F., Bockelmann, E., Grunwald, V., Martín‐Suárez, S., Riecken, K., Witte, O. W., et al. (2023) · The EMBO Journal · doi:10.1038/s44318-023-00011-2 · Cited by 12
“Although D-cyclins are interchangeable in many cellular contexts (Sherr and Roberts, 2004), several lines of evidence suggest that they possess unique roles during nervous system development (Glickstein et al, 2007a; Glickstein et al, 2007b; Lukaszewicz and Anderson, 2011; Wianny et al, 1998).”
BackgroundAssociation between the G870A polymorphism of Cyclin D1 gene and glioma risk
Zong, H., Cao, L., Ma, C., Zhao, J., Ming, X., Shang, M., & Xu, H. (2014) · Tumor Biology · doi:10.1007/s13277-014-1981-2 · Cited by 10
The requirement for cyclin E in c-Myc overexpressing breast cancers
Zhou, Y., Geng, Y., Zhang, Y., Zhou, Y., Chu, C., Sharma, S., Fassl, A., Butter, D., & Siciński, P. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1804720 · Cited by 10
Shining Light on Protein Kinase Biomarkers with Fluorescent Peptide Biosensors
Morris, M. C. (2022) · Life · doi:10.3390/life12040516 · Cited by 10
Zhang, Q., Zhu, H., Cui, Z., Li, Y., Zhuo, J., Ye, J., Zhang, Z., Lian, Z., Du, Q., Zhao, K., et al. (2022) · Biomolecules · doi:10.3390/biom12081114 · Cited by 10
Asano, S., Ono, A., Baba, K., Uehara, T., Sakamoto, K., Hayata‐Takano, A., Nakazawa, T., Yanamoto, S., Tanimoto, K., Hashimoto, H., et al. (2024) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2024.01.002 · Cited by 10
Perspectives in Evo‐Devo of the Vertebrate Brain
Rétaux, S., Bourrat, F., Joly, J., & Hinaux, H. (2013) · Wiley eBooks · doi:10.1002/9781118707449.ch8 · Cited by 11
Effects of Varicella-Zoster Virus on Cell Cycle Regulatory Pathways
Moffat, J. F., & Greenblatt, R. J. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_28 · Cited by 10
“The results followed the known activation pattern of CDKs by sequential expression of cyclins (Fig. 1): (1) cyclin D3 activated CDK4/6 to force exit from G1 (cyclins D1 and D2 were not expressed in this cell type), (2) cyclin E activated CDK2 briefly around the restriction point before S phase, (3) cyclin A activated…”
BackgroundHarrison, T. A., Adams, L. B. S., Moore, P. D., Perna, M. K., Sword, J. D., & Defoe, D. M. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-34 · Cited by 10
“These signals alter the expression or activity of proteins that constitute the core cell cycle machinery, including cyclin-dependent kinases (Cdks), which trigger different phases of the cell cycle [47,48], and proteins that regulate Cdk activity positively (e.”
BackgroundLi, J., Warner, B. M., Casto, B. C., Knobloch, T. J., & Weghorst, C. M. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20424 · Cited by 12
“andnegativelymodulatesE2F-mediated transcription of genes required for the G1-to-S transition [1].”
BackgroundSoomro, J., Lu, Z., Gui, H., Zhang, B., & Shen, Z. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00496 · Cited by 12
“The activity of cyclin E requires CDK2 with which it forms cyclin E1/CDK2 complex that derives the cell cycle through late G1/S phase (Sherr and Roberts, 1999, 2004).”
BackgroundZhao, Z., Yang, F., Liu, Y., Fu, K., & Jing, S. (2018) · Oncology Letters · doi:10.3892/ol.2018.9246 · Cited by 10
Roliński, M., Montaldo, N. P., Aksu, M. E., Martin, S. L. F., Brambilla, A., Kunath, N., Johansen, J. A., Erlandsen, S. E., Liabakk, N., Rian, K., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1289 · Cited by 11
“Its expression is regulated both at transcriptional and posttranscriptional level, and several cyclin D1 activators and repressors were identified (20,21).”
CHREBP suppresses gastric cancer progression via the cyclin D1-Rb-E2F1 pathway
Zhang, J., Zhang, J., Fu, Z., Zhang, Y., Luo, Z., Zhang, P., Xu, Y., & Huang, C. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01079-1 · Cited by 11
“Importantly, cyclin D1 upregulation induces DNA repair/ replication process, which is relevant to genetic instability via promoting the frequency of gene deficiency or gene amplification [30].”
BackgroundAsad, M. J., Chen, J., Liao, J., Liu, D., Yu, J., & Yang, G. (2022) · Biology · doi:10.3390/biology11101493 · Cited by 10
“Changes in cyclin concentration produce sequential activation or deactivation of the CDK catalytic partners, leading to the periodic development of cells through the cell cycle [5,6].”
BackgroundCAI, L., Ye, H., YU, F., Li, H., Chen, J., & Liu, X. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1368 · Cited by 10
The Rho-Regulated ROCK Kinases in Cancer
Wickman, G., Samuel, M. S., Lochhead, P. A., & Olson, M. F. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1111-7_11 · Cited by 12
Yeast culture in weaned lamb feed: a proteomic journey into enhanced rumen health and growth
Li, X., Yang, X., Chen, H., Liu, S., Hao, P., Ning, J., Wu, Y., Liang, X., Zhang, Y., & Liu, D. (2025) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-025-01223-8 · Cited by 9
“In the late G 1 phase, cyclin E activates CDK2, resulting in complete Rb phosphorylation and E2F-driven transcription [57, 60].”
Parathyroid hormone and the regulation of cell cycle in colon adenocarcinoma cells
Calvo, N., Gentili, C., & de Boland, A. R. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.06.001 · Cited by 9
Wang, Y., Li, Y., Liu, D., Zheng, D., Li, X., Li, C., Huang, C., Wang, Y., Wang, X., Li, Q., et al. (2023) · Molecules · doi:10.3390/molecules28135047 · Cited by 10
“In contrast, unphosphorylated Rb interacts with E2F transcription factors and inhibits E2F target gene expression and G1/S cell cycle transition [22].”
BackgroundmiR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A
Song, S., Xie, S., Liu, X., Li, S., Wang, L., Jiang, X., & Lu, D. (2023) · Non-coding RNA Research · doi:10.1016/j.ncrna.2023.10.005 · Cited by 9
“The activity of cell-cycle proteins is tightly controlled by their cell-cycle-specific transcription, protein degradation, as well as by several CDK inhibitor proteins [33].”
BackgroundRegulation of p27kip1 mRNA Expression by MicroRNAs
Martínez-Sánchez, A., & Gebauer, F. (2009) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-03103-8_4 · Cited by 10
“The activity of CDKs, in turn, is regulated by their association with regulatory cyclin subunits, the phosphorylation of their catalytic kinase subunits, their subcellular localization, and their binding to regulatory proteins called cyclin-dependent kinase inhibitors (CKIs) (reviewed in Malumbres and Barbacid 2007; S…”
BackgroundKim, K. A. (2013) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000180 · Cited by 9
“Three D type cyclins (cyclin D1, D2 and D3) bind to CDK4 and CDK6, which are essential for entry into G1 phase [6].”
BackgroundDifferential Expression and Prognostic Value of Cytoplasmic and Nuclear Cyclin D1 in Prostate Cancer
Cao, Z., Chen, X., Xu, Y., Guo, F., Ji, J., Xu, H., He, J., Sun, Y., & Wang, F. (2020) · BioMed Research International · doi:10.1155/2020/1692658 · Cited by 10
“After been activated by phosphorylation, the CCND1-CDK complex enters the nucleus by active transport or via nuclear pores [20, 21], and this complex regulates the cell cycle by phosphorylating (1) S-phase gene expression negative regulators and (2) a class of Cdk inhibitors [8, 22].”
BackgroundWu, H., Wang, C., Liu, Y., Yang, C., Liang, X., Zhang, X., & Li, X. (2020) · Oncology Letters · doi:10.3892/ol.2020.12127 · Cited by 10
“CCND3 is one of the three well‐known members of the D cyclin family that serves a critical role in the mammalian cell cycle machinery (36,37).”
BackgroundAnbara, H., Shahrooz, R., Razi, M., Malekinejad, H., Najafi, G., & Jalali, A. S. (2022) · Environmental Toxicology · doi:10.1002/tox.23470 · Cited by 9
A differential response to newt regeneration extract by C2C12 and primary mammalian muscle cells
Kawesa, S., Vanstone, J. R., & Tsilfidis, C. (2015) · Skeletal Muscle · doi:10.1186/s13395-015-0044-8 · Cited by 9
“As a result, pRb dissociates from E2F, a transcriptional factor, which activates cyclin E and A, and this pushes the cell through the cell cycle (Sherr and Roberts, 2004).”
BackgroundWu, D., Zhang, X., Liu, Z., Yan, H., Mai, J., Zhao, Z., Zhong, Q., & Liu, X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.051 · Cited by 9
Guo, Y. C., Mahajan, A., Yuan, C., Joo, S. H., Weghorst, C. M., Tsai, M., & Li, J. (2009) · Biochemistry · doi:10.1021/bi802247p · Cited by 13
Boutchueng-Djidjou, M., Belleau, P., Bilodeau, N., Fortier, S., Bourassa, S., Droit, A., Elowe, S., & Faure, R. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205180 · Cited by 11
“318 Indeed, mice lacking Cdk2 are viable [51, 52] and targeted Cdk2 deletion in the pancreas 319 induces glucose intolerance primarily by affecting glucose-stimulated insulin secretion [53].”
BackgroundDifferences in regulation and function of E-cyclins in human cancer cells
Geng, Y., & Siciński, P. (2013) · Cell Cycle · doi:10.4161/cc.24487 · Cited by 9
Identification of cell cycle-targeting microRNAs through genome-wide screens
Hydbring, P., Wang, Y., Bogorad, R. L., Yin, H., Anderson, D. G., Cheng, L., & Siciński, P. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1380132 · Cited by 9
“Progression through the S phase is driven by cyclin A2-CDK2 kinase, while cyclin B-CDK1 regulates multiple mitotic events preceding cell division.(1,2)”
BackgroundHamanaka, J., Mikami, Y., Horiuchi, A., Yano, A., Amano, F., Shibata, S., Ogata, A., Ogata, K., Nagatsu, A., Miura, N., et al. (2024) · Traditional & Kampo Medicine · doi:10.1002/tkm2.1441 · Cited by 8
“Cyclin and cyclin-dependent kinases play crucial roles in regulating cell cycle events [30].”
Sun, J., Liang, S., Liu, X., Zhang, S., Li, M., Zhang, Q., & Chen, J. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2294175 · Cited by 8
“In metazoans, CDK4 and CDK6 are primarily responsible for cell cycle entry, and they respond to many growth-regulatory signals (D. O. Morgan, 1997; Sherr & Roberts, 2004).”
Zhou, M. L., Duan, L., Chen, J., Li, Y., Yin, Z., Song, S., Cao, Y., Luo, P., Hu, F., Yang, G., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01513-0 · Cited by 8
“…controlled process, and the activity of cell cycle proteins in normal cells is strictly controlled by cell cycle-specific transcription, protein degradation, and related CDK inhibitor proteins [5], machinery that is often disrupted in most human cancers, leading to the progression of malignancy.”
BackgroundCell Polarity and Initiation of Migration
Sekine, K., Tabata, H., & Nakajima, K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397266-8.00024-7 · Cited by 8
Reduced expression of microRNA-206 regulates cell proliferation via cyclinD2 in gliomas
Yang, X., Zhang, C., Guo, T.-Z., Feng, Y., LIU, Q., Chen, Y., & Zhang, Q. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3171 · Cited by 8
“In the process of tumor formation, disruption of cell cycle progression from G 1 to S phase is commonly observed (21).”
Wang, Z., Hu, T., Jin, C., Yu, J., Zhu, D., & Liu, J. (2020) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-20-387 · Cited by 8
“In eukaryotic cells, cyclin-dependent kinases (CDKs) are key factors in cell cycle regulation, and their activation is regulated by related cell cycle proteins (16).”
Background
Metadata
- Authors
- Sherr, C. J., & Roberts, J. M.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-11-15
- Volume
- 18
- Issue
- 22
- Pages
- 2699-2711
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2152107294
- Cited by
- 1,089
- References
- 115
- Citations by year
- 2026: 13 · 2025: 36 · 2024: 48 · 2023: 38 · 2022: 34 · 2021: 42 · 2020: 49 · 2019: 50 · 2018: 36 · 2017: 35 · 2016: 42 · 2015: 51 · 2014: 47 · 2013: 52 · 2012: 62
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- cyclin-dependent kinases, cyclins, D-type cyclins, G1 phase, cell cycle progression, CDK4, CDK6, CDK2, cyclin E, cyclin D, fetal development, mitogenic signaling
- MeSH terms
- Animals, Cell Cycle, Humans, Signal Transduction, Cyclins, Mice, Knockout, Cyclin-Dependent Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.